Marathon Biopharmaceuticals LLC

now Cambrex Bio Science Hopkinton, Inc.; previously owned by Seragen, then Boston Univ., then Ligand; acquired by CoPharma Inc. in Jan. 2000; acquired by Cambrex in Oct. 2003